Sara Bellavita
Family · Hackensack, NJNPI 1932615002
Payments from drug & device makers
Across 131 payments — averaging $19.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$348
- AstraZeneca$319
- Johnson & Johnson$296
- Merck$249
- Taiho Oncology, Inc.$183
- Astellas Pharma US Inc$147
- plus $947 from 25 others
What the payments were for
- Food & beverage$2,22189%
- Education$26811%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 24 | $348 |
| AstraZeneca | 15 | $319 |
| Johnson & Johnson | 13 | $296 |
| Merck | 14 | $249 |
| Taiho Oncology, Inc. | 10 | $183 |
| Astellas Pharma US Inc | 8 | $147 |
| Regeneron Healthcare Solutions, Inc. | 6 | $107 |
| Seagen Inc. | 1 | $99 |
| Bayer | 4 | $88 |
| GSK | 4 | $68 |
| AbbVie | 4 | $67 |
| Ipsen Biopharmaceuticals, Inc | 3 | $49 |
| Pharmacosmos Therapeutics Inc. | 2 | $40 |
| Novartis | 2 | $37 |
| Array Biopharma Inc | 2 | $36 |
| Janssen Scientific Affairs, LLC | 2 | $36 |
| Galvanize Therapeutics, Inc | 1 | $36 |
| Eisai Inc. | 2 | $35 |
| Amgen | 2 | $28 |
| Novocure Inc. | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $20 |
| Cumberland Pharmaceuticals, Inc. | 1 | $20 |
| Immunocore Limited | 1 | $19 |
| Tersera Therapeutics LLC | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Stemline Therapeutics Inc. | 1 | $17 |
| Agios Pharmaceuticals, Inc. | 1 | $17 |
| EMD Serono, Inc. | 1 | $17 |
| Beone Medicines USA, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
How this compares
$2,489 in reported general payments places this provider in the 85th percentile of 2,692 family providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prochlorperazine Maleate | 23 | $294 |
| Oxycodone Hcl | 14 | $159 |
| Prednisone | 27 | $142 |
| Ondansetron Hcl | 17 | $84 |
| Lorazepam | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other family in Hackensack
- Bianca CorsiHackensack$9K
- Jennifer DemaioMorristown$412K
- Kara TrlicaCranbury$186K
- Nicole BauerParamus$161K
- Angie GarciaWest New York$161K
- China BattistaWall Township$142K
- Nancy EisenbergerVoorhees$82K
- Jennifer AbitabiloGlen Ridge$54K
- Megan FiloramoMorristown$53K
- Shawn DenningToms River$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.